Related references
Note: Only part of the references are listed.Why Most Acute Stroke Studies Are Positive in Animals but Not in Patients: A Systematic Comparison of Preclinical, Early Phase, and Phase 3 Clinical Trials of Neuroprotective Agents
Antje Schmidt-Pogoda et al.
ANNALS OF NEUROLOGY (2020)
NK cells in cerebral ischemia
Chen Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Interleukin 15 blockade protects the brain from cerebral ischemia-reperfusion injury
Gilbert Aaron Lee et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury
Wei-Na Jin et al.
STROKE (2018)
Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke
Qianyi He et al.
MOLECULAR IMMUNOLOGY (2018)
Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity
Minshu Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
B cells do not have a major pathophysiologic role in acute ischemic stroke in mice
Michael K. Schuhmann et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Poststroke Inflammasome Expression and Regulation in the Peri-Infarct Area by Gonadal Steroids after Transient Focal Ischemia in the Rat Brain
Leoni Lammerding et al.
NEUROENDOCRINOLOGY (2016)
Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy
Reza Ghasemi et al.
NATURE COMMUNICATIONS (2016)
CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke
Michael K. Schuhmann et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
High natural killer cell number might identify stroke patients at risk of developing infections
Sylvie De Raedt et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer Cells
Jenny M. Karo et al.
CELL (2014)
Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10
Yao Zhang et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Antigen Dependently Activated Cluster of Differentiation 8-Positive T Cells Cause Perforin-Mediated Neurotoxicity in Experimental Stroke
Eva Mracsko et al.
JOURNAL OF NEUROSCIENCE (2014)
Ischemic neurons recruit natural killer cells that accelerate brain infarction
Yan Gan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature
Christoph Kleinschnitz et al.
BLOOD (2013)
Postischemic Brain Infiltration of Leukocyte Subpopulations Differs among Murine Permanent and Transient Focal Cerebral Ischemia Models
Wei Zhou et al.
BRAIN PATHOLOGY (2013)
Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO
Tobias Stubbe et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
FTY720 Ameliorates Acute Ischemic Stroke in Mice by Reducing Thrombo-Inflammation but Not by Direct Neuroprotection
Peter Kraft et al.
STROKE (2013)
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
Patrick J. Brennan et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells
Emilie Narni-Mancinelli et al.
INTERNATIONAL IMMUNOLOGY (2011)
Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation
Christoph Kleinschnitz et al.
BLOOD (2010)
Mechanisms Underlying the Cerebral Microvascular Responses to Angiotensin II-Induced Hypertension
Shantel A. Vital et al.
MICROCIRCULATION (2010)
Improving outcome after stroke: Overcoming the translational roadblock
Matthias Endres et al.
CEREBROVASCULAR DISEASES (2008)
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1null) interleukin (IL)-2 receptor common gamma chain (IL2rγnull) null mice:: a radioresistant model for human lymphohaematopoietic engraftment
T. Pearson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Human NK Cells Kill Resting but Not Activated Microglia via NKG2D-and NKp46-Mediated Recognition
Anna Luenemann et al.
JOURNAL OF IMMUNOLOGY (2008)
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans
Karl Georg Haeusler et al.
CEREBROVASCULAR DISEASES (2008)
Role of T lymphocytes and interferon-γ in ischemic stroke
G Yilmaz et al.
CIRCULATION (2006)
Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice -: a novel thymic subset defined in BALB.NK mice
M Stenström et al.
IMMUNOLOGY (2005)
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
MR Verneris et al.
BLOOD (2004)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia
CE Junge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells
M Ito et al.
BLOOD (2002)
Share Paper
